S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Pacific Biosciences of CaliforniaQuanterixAccelerate DiagnosticsFluidigmEyepoint Pharmaceuticals
SymbolNASDAQ:PACBNASDAQ:QTRXNASDAQ:AXDXNASDAQ:FLDMNASDAQ:EYPT
Price Information
Current Price$4.49$28.40$16.13$3.77$1.57
52 Week RangeHoldBuyHoldBuyBuy
Analyst Ratings
Consensus RecommendationHoldBuyHoldBuyBuy
Consensus Price Target$7.67$35.00$18.33$11.75$4.38
% Upside from Price Target70.75% upside23.24% upside13.66% upside211.67% upside178.66% upside
Trade Information
Market Cap$682.20 million$777.69 million$884.78 million$265.06 million$204.48 million
Beta1.761.272.842.341.58
Average Volume1,972,830127,049152,787596,530577,686
Sales & Book Value
Annual Revenue$90.89 million$37.63 million$5.67 million$117.24 million$2.96 million
Price / Sales7.5621.14155.472.2457.35
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.76 per share$1.85 per share$1.06 per share$1.46 per shareN/A
Price / Book5.9115.3515.222.58
Profitability
Net Income$-84,130,000.00$-31,540,000.00$-88,330,000.00$-64,790,000.00$-53,170,000.00
EPS($0.55)($1.43)($1.62)($0.53)($0.58)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-92.57%-75.78%-1,116.69%-55.26%-409.07%
Return on Equity (ROE)-113.89%-54.74%-249.46%-20.31%-250.32%
Return on Assets (ROA)-50.25%-37.51%-51.36%-12.44%-63.54%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.84%0.06%12.81%0.33%3.12%
Current Ratio1.52%7.61%21.93%2.89%4.54%
Quick Ratio1.22%7.00%20.65%2.44%4.29%
Ownership Information
Institutional Ownership Percentage68.76%67.84%56.15%92.22%57.52%
Insider Ownership Percentage11.60%30.80%47.60%2.20%41.29%
Miscellaneous
Employees40117728753555
Shares Outstanding152.96 million28.02 million54.65 million69.57 million108.12 million
Next Earnings Date5/1/2020 (Estimated)3/16/2020 (Estimated)2/27/2020 (Confirmed)5/7/2020 (Estimated)3/12/2020 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel